(PM) Philip Morris International - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7181721090
Stock: Cigarettes, Heat-Not-Burn, E-Vapor, Oral Nicotine, Accessories
Total Rating 52
Risk 79
Buy Signal -0.71
| Risk 5d forecast | |
|---|---|
| Volatility | 28.5% |
| Relative Tail Risk | -5.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | 8.99 |
| Character TTM | |
|---|---|
| Beta | -0.179 |
| Beta Downside | 0.247 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.64% |
| CAGR/Max DD | 1.29 |
EPS (Earnings per Share)
Revenue
Description: PM Philip Morris International March 02, 2026
Philip Morris International Inc. (NYSE: PM) is a global tobacco firm that sells traditional cigarettes and a growing portfolio of smoke-free products-including heat-not-burn IQOS, e-vapor VEEV, and oral nicotine ZYN-alongside consumer accessories and wellness items. The company, incorporated in 1987, is headquartered in Stamford, Connecticut, and operates under the GICS Tobacco sub-industry.
Recent performance highlights include FY 2023 net revenue of $29.7 billion, a 4% year-over-year increase driven largely by a 12% rise in IQOS sales and a 15% jump in ZYN volumes. Adjusted earnings per share reached $6.00, reflecting improved margins as the firm shifts toward higher-margin reduced-risk products. Key sector drivers remain tightening regulatory environments and a consumer pivot toward reduced-risk alternatives, while macro-economic pressures such as inflation and discretionary spending trends continue to shape demand.
For a deeper dive, check out ValueRay’s analysis.
Headlines to watch out for
- IQOS heat-not-burn product sales drive revenue growth
- Cigarette volume declines impact traditional revenue
- Regulatory restrictions on tobacco products increase compliance costs
- Currency fluctuations affect international earnings
- Excise taxes on tobacco products reduce profitability
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 11.35b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -2.02 > 1.0 |
| NWC/Revenue: -2.62% < 20% (prev -7.25%; Δ 4.63% < -1%) |
| CFO/TA 0.18 > 3% & CFO 12.23b > Net Income 11.35b |
| Net Debt (43.96b) to EBITDA (17.46b): 2.52 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.56b) vs 12m ago 0.13% < -2% |
| Gross Margin: 67.12% > 18% (prev 0.65%; Δ 6.65k% > 0.5%) |
| Asset Turnover: 62.07% > 50% (prev 61.31%; Δ 0.77% > 0%) |
| Interest Coverage Ratio: 9.75 > 6 (EBITDA TTM 17.46b / Interest Expense TTM 1.59b) |
Altman Z'' 3.47
| A: -0.02 (Total Current Assets 24.36b - Total Current Liabilities 25.43b) / Total Assets 69.19b |
| B: 0.51 (Retained Earnings 35.40b / Total Assets 69.19b) |
| C: 0.24 (EBIT TTM 15.47b / Avg Total Assets 65.48b) |
| D: 0.30 (Book Value of Equity 23.10b / Total Liabilities 77.21b) |
| Altman-Z'' Score: 3.47 = A |
Beneish M -2.92
| DSRI: 1.16 (Receivables 5.81b/4.67b, Revenue 40.65b/37.88b) |
| GMI: 0.97 (GM 67.12% / 64.81%) |
| AQI: 0.95 (AQ_t 0.53 / AQ_t-1 0.56) |
| SGI: 1.07 (Revenue 40.65b / 37.88b) |
| TATA: -0.01 (NI 11.35b - CFO 12.23b) / TA 69.19b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
What is the price of PM shares?
As of March 24, 2026, the stock is trading at USD 163.24 with a total of 2,689,930 shares traded.
Over the past week, the price has changed by -5.77%, over one month by -12.03%, over three months by +2.55% and over the past year by +11.53%.
Over the past week, the price has changed by -5.77%, over one month by -12.03%, over three months by +2.55% and over the past year by +11.53%.
Is PM a buy, sell or hold?
Philip Morris International has received a consensus analysts rating of 4.06.
Therefore, it is recommended to buy PM.
- StrongBuy: 7
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the PM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 194.8 | 19.4% |
| Analysts Target Price | 194.8 | 19.4% |
PM Fundamental Data Overview March 24, 2026
P/E Trailing = 22.4669
P/E Forward = 19.305
P/S = 6.2466
P/B = -29.62
P/EG = 1.8632
Revenue TTM = 40.65b USD
EBIT TTM = 15.47b USD
EBITDA TTM = 17.46b USD
Long Term Debt = 45.13b USD (from longTermDebt, last quarter)
Short Term Debt = 3.70b USD (from shortTermDebt, last quarter)
Debt = 48.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 43.96b USD (from netDebt column, last quarter)
Enterprise Value = 297.87b USD (253.91b + Debt 48.84b - CCE 4.87b)
Interest Coverage Ratio = 9.75 (Ebit TTM 15.47b / Interest Expense TTM 1.59b)
EV/FCF = 27.93x (Enterprise Value 297.87b / FCF TTM 10.66b)
FCF Yield = 3.58% (FCF TTM 10.66b / Enterprise Value 297.87b)
FCF Margin = 26.23% (FCF TTM 10.66b / Revenue TTM 40.65b)
Net Margin = 27.92% (Net Income TTM 11.35b / Revenue TTM 40.65b)
Gross Margin = 67.12% ((Revenue TTM 40.65b - Cost of Revenue TTM 13.37b) / Revenue TTM)
Gross Margin QoQ = 65.64% (prev 67.85%)
Tobins Q-Ratio = 4.31 (Enterprise Value 297.87b / Total Assets 69.19b)
Interest Expense / Debt = 1.72% (Interest Expense 839.0m / Debt 48.84b)
Taxrate = 23.08% (675.0m / 2.92b)
NOPAT = 11.90b (EBIT 15.47b * (1 - 23.08%))
Current Ratio = 0.96 (Total Current Assets 24.36b / Total Current Liabilities 25.43b)
Debt / Equity = -4.89 (negative equity) (Debt 48.84b / totalStockholderEquity, last quarter -9.99b)
Debt / EBITDA = 2.52 (Net Debt 43.96b / EBITDA 17.46b)
Debt / FCF = 4.12 (Net Debt 43.96b / FCF TTM 10.66b)
Total Stockholder Equity = -10.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.33% (Net Income 11.35b / Total Assets 69.19b)
RoE = -103.7% (negative equity) (Net Income TTM 11.35b / Total Stockholder Equity -10.94b)
RoCE = 45.24% (EBIT 15.47b / Capital Employed (Equity -10.94b + L.T.Debt 45.13b))
RoIC = 30.47% (NOPAT 11.90b / Invested Capital 39.05b)
WACC = 4.70% (E(253.91b)/V(302.75b) * Re(5.35%) + D(48.84b)/V(302.75b) * Rd(1.72%) * (1-Tc(0.23)))
Discount Rate = 5.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.13%
[DCF] Terminal Value 86.38% ; FCFF base≈10.71b ; Y1≈10.75b ; Y5≈11.50b
[DCF] Fair Price = 191.2 (EV 341.63b - Net Debt 43.96b = Equity 297.67b / Shares 1.56b; r=6.0% [WACC]; 5y FCF grow -0.09% → 3.0% )
EPS Correlation: 65.03 | EPS CAGR: 2.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 94.97 | Revenue CAGR: 8.07% | SUE: -0.06 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.15 | Chg7d=-0.003 | Chg30d=-0.011 | Revisions Net=+2 | Analysts=9
EPS current Year (2026-12-31): EPS=8.44 | Chg7d=-0.001 | Chg30d=+0.040 | Revisions Net=+6 | Growth EPS=+11.9% | Growth Revenue=+7.5%
EPS next Year (2027-12-31): EPS=9.20 | Chg7d=+0.000 | Chg30d=+0.012 | Revisions Net=+1 | Growth EPS=+9.0% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = +2.5% (Analyst 6.0% - Implied 3.5%)
P/E Forward = 19.305
P/S = 6.2466
P/B = -29.62
P/EG = 1.8632
Revenue TTM = 40.65b USD
EBIT TTM = 15.47b USD
EBITDA TTM = 17.46b USD
Long Term Debt = 45.13b USD (from longTermDebt, last quarter)
Short Term Debt = 3.70b USD (from shortTermDebt, last quarter)
Debt = 48.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 43.96b USD (from netDebt column, last quarter)
Enterprise Value = 297.87b USD (253.91b + Debt 48.84b - CCE 4.87b)
Interest Coverage Ratio = 9.75 (Ebit TTM 15.47b / Interest Expense TTM 1.59b)
EV/FCF = 27.93x (Enterprise Value 297.87b / FCF TTM 10.66b)
FCF Yield = 3.58% (FCF TTM 10.66b / Enterprise Value 297.87b)
FCF Margin = 26.23% (FCF TTM 10.66b / Revenue TTM 40.65b)
Net Margin = 27.92% (Net Income TTM 11.35b / Revenue TTM 40.65b)
Gross Margin = 67.12% ((Revenue TTM 40.65b - Cost of Revenue TTM 13.37b) / Revenue TTM)
Gross Margin QoQ = 65.64% (prev 67.85%)
Tobins Q-Ratio = 4.31 (Enterprise Value 297.87b / Total Assets 69.19b)
Interest Expense / Debt = 1.72% (Interest Expense 839.0m / Debt 48.84b)
Taxrate = 23.08% (675.0m / 2.92b)
NOPAT = 11.90b (EBIT 15.47b * (1 - 23.08%))
Current Ratio = 0.96 (Total Current Assets 24.36b / Total Current Liabilities 25.43b)
Debt / Equity = -4.89 (negative equity) (Debt 48.84b / totalStockholderEquity, last quarter -9.99b)
Debt / EBITDA = 2.52 (Net Debt 43.96b / EBITDA 17.46b)
Debt / FCF = 4.12 (Net Debt 43.96b / FCF TTM 10.66b)
Total Stockholder Equity = -10.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.33% (Net Income 11.35b / Total Assets 69.19b)
RoE = -103.7% (negative equity) (Net Income TTM 11.35b / Total Stockholder Equity -10.94b)
RoCE = 45.24% (EBIT 15.47b / Capital Employed (Equity -10.94b + L.T.Debt 45.13b))
RoIC = 30.47% (NOPAT 11.90b / Invested Capital 39.05b)
WACC = 4.70% (E(253.91b)/V(302.75b) * Re(5.35%) + D(48.84b)/V(302.75b) * Rd(1.72%) * (1-Tc(0.23)))
Discount Rate = 5.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 0.13%
[DCF] Terminal Value 86.38% ; FCFF base≈10.71b ; Y1≈10.75b ; Y5≈11.50b
[DCF] Fair Price = 191.2 (EV 341.63b - Net Debt 43.96b = Equity 297.67b / Shares 1.56b; r=6.0% [WACC]; 5y FCF grow -0.09% → 3.0% )
EPS Correlation: 65.03 | EPS CAGR: 2.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 94.97 | Revenue CAGR: 8.07% | SUE: -0.06 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.15 | Chg7d=-0.003 | Chg30d=-0.011 | Revisions Net=+2 | Analysts=9
EPS current Year (2026-12-31): EPS=8.44 | Chg7d=-0.001 | Chg30d=+0.040 | Revisions Net=+6 | Growth EPS=+11.9% | Growth Revenue=+7.5%
EPS next Year (2027-12-31): EPS=9.20 | Chg7d=+0.000 | Chg30d=+0.012 | Revisions Net=+1 | Growth EPS=+9.0% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 7.9% - Earnings Yield 4.5%)
[Growth] Growth Spread = +2.5% (Analyst 6.0% - Implied 3.5%)